Low-level vancomycin resistance in Staphylococcus aureus?an Australian perspective

This publication has 39 references indexed in Scilit:

• Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals
  Clinical Microbiology & Infection, 2004
• Alterations of Cell Wall Structure and MetabolismAccompany Reduced Susceptibility to Vancomycin in an IsogenicSeries of Clinical Isolates of Staphylococcusaureus
  Journal of Bacteriology, 2003
• Microarray Transcription Analysis of Clinical Staphylococcus aureus Isolates Resistant to Vancomycin
  Journal of Bacteriology, 2003
• Influence of Reduced Susceptibility to Glycopeptides on Activities of Vancomycin and Teicoplanin against Staphylococcus aureus in Experimental Endocarditis
  Antimicrobial Agents and Chemotherapy, 2003
• Vancomycin Treatment Failure Associated with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus in a Patient with Endocarditis and in the Rabbit Model of Endocarditis
  Antimicrobial Agents and Chemotherapy, 2003
• The Prevalence and Mechanisms of Vancomycin Resistance in Staphylococcus Aureus
  Annual Review of Microbiology, 2002
• Nationwide Survey Shows that Methicillin-Resistant Staphylococcus aureus Strains Heterogeneously and Intermediately Resistant to Vancomycin Are Not Disseminated throughout Japanese Hospitals
  Journal of Clinical Microbiology, 2001
• Involvement of multiple genetic loci inStaphylococcus aureusteicoplanin resistance
  FEMS Microbiology Letters, 2001
• Identification of the Up- and Down-Regulated Genes in Vancomycin-Resistant Staphylococcus aureus Strains Mu3 and Mu50 by cDNA Differential Hybridization Method
  Biochemical and Biophysical Research Communications, 2000
• Emergence of Teicoplanin Resistance During Therapy of Staphylococcus aureus Endocarditis
  The Journal of Infectious Diseases, 1990